On September 14, 2020 Monopar Therapeutics Inc. (Nasdaq: MNPR) reported that Chandler D. Robinson, MD, Chief Executive Officer, will present a corporate update at the H.C. Wainwright 22nd Annual Global Investment Conference, Healthcare & Biotech Track (Press release, Monopar Therapeutics, SEP 14, 2020, https://ir.monopartx.com/news/detail/18/monopar-therapeutics-to-present-at-the-h-c-wainwright-22nd-annual-global-investment-conference-on-september-16-2020 [SID1234565086]). The conference will be held virtually.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Presentation Details:
Date: Wednesday, September 16, 2020
Time: 1:30 PM EDT
Location: Virtual
For more information, please contact investor relations at [email protected].